Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03436784 · ClinicalTrials.gov registry record · NA

The Indiana SNAP-Ed Long-term Study Sequel

A NA study, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
261
Enrollment target

NCT03436784: Completed NA study, sponsored by Purdue University.

NCT03436784 is a NA study that has completed, run by Purdue University. The registered enrollment target is 261 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03436784, a NA study, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
261 participants
Enrollment target

Study Summary

The goal of the study is to determine the immediate and long-term effects of SNAP-Ed on the dietary intake of participants.

Primary Outcome

The Healthy Eating Index-2010 was used to characterize diet quality from National Cancer Institute Automated Self-Administered 24-hour Dietary Recall Tool

Interventions

  • BEHAVIORAL Indiana SNAP-Ed

Trial Details

FieldValue
Enrollment Target 261 participants
Start Date 2015-09-08
Est. Completion 2017-05-01
Phase NA
Purdue University

141 total trials

What the finished NCT03436784 record still lists

NCT03436784 is an interventional study that assigns participants to a tested intervention. The registered 261 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Indiana SNAP-Ed is the first listed.

NCT03436784 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03436784 about?

NCT03436784 is a clinical study titled "The Indiana SNAP-Ed Long-term Study Sequel". The goal of the study is to determine the immediate and long-term effects of SNAP-Ed on the dietary intake of participants.

What is the current status of trial NCT03436784?

This trial is currently completed. It is a NA study. The enrollment target is 261 participants. The study started on 2015-09-08. Estimated completion is 2017-05-01.

What interventions are being tested in trial NCT03436784?

The interventions under investigation include: Indiana SNAP-Ed (BEHAVIORAL).

Who is sponsoring clinical trial NCT03436784?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03436784's enrollment target sits among peer trials

261 397th of 2000 higher than 1,604 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05124912 · 261 participants · NA

    REMASTer: REcurrent Brain Metastases After SRS Trial

  • NCT06559891 · 261 participants · NA

    THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • NCT03713268 · 262 participants

    Intraoperative OCT Guidance of Intraocular Surgery II

  • NCT06074380 · 262 participants · Phase 4

    Non Inferiority Trial Investigating Surfactants Administered Via MIST

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03436784, the US trial registry maintained by the National Library of Medicine. NCT03436784 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.